Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lushou Anshen Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanhaidan Pharmaceutical. It is formulated as an oral granule and is primarily indicated for the treatment of insomnia, dizziness, and fatigue associated with liver-kidney deficiency and heart-spleen deficiency. The medication is a multi-ingredient formulation containing herbal extracts and animal-derived components such as deer horn glue. Its therapeutic actions are based on TCM principles, focusing on nourishing the liver and kidney, tonifying the heart and spleen, and calming the mind (Anshen). It is an approved pharmaceutical product in China, regulated as a Chinese Patent Medicine (CPM).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lushou Anshen Granules.